Helminth Coinfections Modulate Disease Dynamics and Vaccination Success in the Era of Emerging Infectious Diseases

<b>Background/Objectives</b>: Helminth infections, particularly prevalent in low- and middle-income countries, have been extensively studied for their effects on human health. With the emergence of new infectious diseases like SARS-CoV-2 and Ebola, their impact on disease outcomes become...

Full description

Saved in:
Bibliographic Details
Main Authors: Brice Armel Nembot Fogang, Linda Batsa Debrah, Michael Owusu, George Agyei, Julia Meyer, Jonathan Mawutor Gmanyami, Manuel Ritter, Kathrin Arndts, Derrick Adu Mensah, Tomabu Adjobimey, Achim Hörauf, Alexander Yaw Debrah
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/13/5/436
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850256119397613568
author Brice Armel Nembot Fogang
Linda Batsa Debrah
Michael Owusu
George Agyei
Julia Meyer
Jonathan Mawutor Gmanyami
Manuel Ritter
Kathrin Arndts
Derrick Adu Mensah
Tomabu Adjobimey
Achim Hörauf
Alexander Yaw Debrah
author_facet Brice Armel Nembot Fogang
Linda Batsa Debrah
Michael Owusu
George Agyei
Julia Meyer
Jonathan Mawutor Gmanyami
Manuel Ritter
Kathrin Arndts
Derrick Adu Mensah
Tomabu Adjobimey
Achim Hörauf
Alexander Yaw Debrah
author_sort Brice Armel Nembot Fogang
collection DOAJ
description <b>Background/Objectives</b>: Helminth infections, particularly prevalent in low- and middle-income countries, have been extensively studied for their effects on human health. With the emergence of new infectious diseases like SARS-CoV-2 and Ebola, their impact on disease outcomes become more apparent. While individual studies have explored the impact of helminth co-infections on disease severity and vaccine efficacy, the findings are often inconsistent and context-dependent. Furthermore, the long-term effects of helminth-mediated immunosuppression on vaccine efficacy and its broader implications for co-infections in endemic regions remain not fully understood. <b>Methods</b>: This systematic review conducted in line with the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 2020 guidelines synthesizes the current evidence, identifies patterns, and highlights areas needing further research, offering a cohesive understanding of the topic. PubMed, Scopus, Google Scholar, and Cochrane Library were searched to include studies published from 2003 to February 2025. <b>Results</b>: Co-infection reveals a dual role of helminths in modulating immune responses, with both beneficial and detrimental interactions reported across studies. It may confer benefits against respiratory viral infections by muting hyper-inflammation associated with the severity of conditions like COVID-19, Influenza, and RSV. However, they can exacerbate disease outcomes in most bacteria and blood-borne viral conditions by impairing immune functions, such as neutrophil recruitment and antibody response, leading to more severe infections and higher viral loads. The stage of helminth infection also appears critical, with early-stage infections sometimes offering protection, while late-stage infections may worsen disease outcomes. Helminth infection can also negatively impact vaccine efficacy by suppressing B cell activity, reducing antibody levels, and decreasing vaccine effectiveness against infectious diseases. This immunosuppressive effect may persist after deworming, complicating efforts to restore vaccine efficacy. Maternal helminth infections also significantly influence neonatal immunity, affecting newborn vaccine responses. <b>Conclusions</b>: There is a need for targeted interventions and further research in helminth-endemic regions to mitigate the adverse effects on vaccine efficacy and improve public health outcomes.
format Article
id doaj-art-7b760cda18a640ec8bff669b8e393cfc
institution OA Journals
issn 2076-393X
language English
publishDate 2025-04-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj-art-7b760cda18a640ec8bff669b8e393cfc2025-08-20T01:56:42ZengMDPI AGVaccines2076-393X2025-04-0113543610.3390/vaccines13050436Helminth Coinfections Modulate Disease Dynamics and Vaccination Success in the Era of Emerging Infectious DiseasesBrice Armel Nembot Fogang0Linda Batsa Debrah1Michael Owusu2George Agyei3Julia Meyer4Jonathan Mawutor Gmanyami5Manuel Ritter6Kathrin Arndts7Derrick Adu Mensah8Tomabu Adjobimey9Achim Hörauf10Alexander Yaw Debrah11Department of Clinical Microbiology, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi 00233, GhanaDepartment of Clinical Microbiology, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi 00233, GhanaGerman-West African Centre for Global Health and Pandemic Prevention (G-WAC), Partner Site Kumasi, Kumasi 03220, GhanaDepartment of Clinical Microbiology, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi 00233, GhanaInstitute for Medical Microbiology, Immunology and Parasitology (IMMIP), University Hospital Bonn (UKB), 53127 Bonn, GermanyGerman-West African Centre for Global Health and Pandemic Prevention (G-WAC), Partner Site Kumasi, Kumasi 03220, GhanaInstitute for Medical Microbiology, Immunology and Parasitology (IMMIP), University Hospital Bonn (UKB), 53127 Bonn, GermanyInstitute for Medical Microbiology, Immunology and Parasitology (IMMIP), University Hospital Bonn (UKB), 53127 Bonn, GermanyDepartment of Clinical Microbiology, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi 00233, GhanaInstitute for Medical Microbiology, Immunology and Parasitology (IMMIP), University Hospital Bonn (UKB), 53127 Bonn, GermanyInstitute for Medical Microbiology, Immunology and Parasitology (IMMIP), University Hospital Bonn (UKB), 53127 Bonn, GermanyGerman-West African Centre for Global Health and Pandemic Prevention (G-WAC), Partner Site Kumasi, Kumasi 03220, Ghana<b>Background/Objectives</b>: Helminth infections, particularly prevalent in low- and middle-income countries, have been extensively studied for their effects on human health. With the emergence of new infectious diseases like SARS-CoV-2 and Ebola, their impact on disease outcomes become more apparent. While individual studies have explored the impact of helminth co-infections on disease severity and vaccine efficacy, the findings are often inconsistent and context-dependent. Furthermore, the long-term effects of helminth-mediated immunosuppression on vaccine efficacy and its broader implications for co-infections in endemic regions remain not fully understood. <b>Methods</b>: This systematic review conducted in line with the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 2020 guidelines synthesizes the current evidence, identifies patterns, and highlights areas needing further research, offering a cohesive understanding of the topic. PubMed, Scopus, Google Scholar, and Cochrane Library were searched to include studies published from 2003 to February 2025. <b>Results</b>: Co-infection reveals a dual role of helminths in modulating immune responses, with both beneficial and detrimental interactions reported across studies. It may confer benefits against respiratory viral infections by muting hyper-inflammation associated with the severity of conditions like COVID-19, Influenza, and RSV. However, they can exacerbate disease outcomes in most bacteria and blood-borne viral conditions by impairing immune functions, such as neutrophil recruitment and antibody response, leading to more severe infections and higher viral loads. The stage of helminth infection also appears critical, with early-stage infections sometimes offering protection, while late-stage infections may worsen disease outcomes. Helminth infection can also negatively impact vaccine efficacy by suppressing B cell activity, reducing antibody levels, and decreasing vaccine effectiveness against infectious diseases. This immunosuppressive effect may persist after deworming, complicating efforts to restore vaccine efficacy. Maternal helminth infections also significantly influence neonatal immunity, affecting newborn vaccine responses. <b>Conclusions</b>: There is a need for targeted interventions and further research in helminth-endemic regions to mitigate the adverse effects on vaccine efficacy and improve public health outcomes.https://www.mdpi.com/2076-393X/13/5/436helminthco-infectioninfectious diseasesnon-communicable diseasesimmune responsevaccine efficacy
spellingShingle Brice Armel Nembot Fogang
Linda Batsa Debrah
Michael Owusu
George Agyei
Julia Meyer
Jonathan Mawutor Gmanyami
Manuel Ritter
Kathrin Arndts
Derrick Adu Mensah
Tomabu Adjobimey
Achim Hörauf
Alexander Yaw Debrah
Helminth Coinfections Modulate Disease Dynamics and Vaccination Success in the Era of Emerging Infectious Diseases
Vaccines
helminth
co-infection
infectious diseases
non-communicable diseases
immune response
vaccine efficacy
title Helminth Coinfections Modulate Disease Dynamics and Vaccination Success in the Era of Emerging Infectious Diseases
title_full Helminth Coinfections Modulate Disease Dynamics and Vaccination Success in the Era of Emerging Infectious Diseases
title_fullStr Helminth Coinfections Modulate Disease Dynamics and Vaccination Success in the Era of Emerging Infectious Diseases
title_full_unstemmed Helminth Coinfections Modulate Disease Dynamics and Vaccination Success in the Era of Emerging Infectious Diseases
title_short Helminth Coinfections Modulate Disease Dynamics and Vaccination Success in the Era of Emerging Infectious Diseases
title_sort helminth coinfections modulate disease dynamics and vaccination success in the era of emerging infectious diseases
topic helminth
co-infection
infectious diseases
non-communicable diseases
immune response
vaccine efficacy
url https://www.mdpi.com/2076-393X/13/5/436
work_keys_str_mv AT bricearmelnembotfogang helminthcoinfectionsmodulatediseasedynamicsandvaccinationsuccessintheeraofemerginginfectiousdiseases
AT lindabatsadebrah helminthcoinfectionsmodulatediseasedynamicsandvaccinationsuccessintheeraofemerginginfectiousdiseases
AT michaelowusu helminthcoinfectionsmodulatediseasedynamicsandvaccinationsuccessintheeraofemerginginfectiousdiseases
AT georgeagyei helminthcoinfectionsmodulatediseasedynamicsandvaccinationsuccessintheeraofemerginginfectiousdiseases
AT juliameyer helminthcoinfectionsmodulatediseasedynamicsandvaccinationsuccessintheeraofemerginginfectiousdiseases
AT jonathanmawutorgmanyami helminthcoinfectionsmodulatediseasedynamicsandvaccinationsuccessintheeraofemerginginfectiousdiseases
AT manuelritter helminthcoinfectionsmodulatediseasedynamicsandvaccinationsuccessintheeraofemerginginfectiousdiseases
AT kathrinarndts helminthcoinfectionsmodulatediseasedynamicsandvaccinationsuccessintheeraofemerginginfectiousdiseases
AT derrickadumensah helminthcoinfectionsmodulatediseasedynamicsandvaccinationsuccessintheeraofemerginginfectiousdiseases
AT tomabuadjobimey helminthcoinfectionsmodulatediseasedynamicsandvaccinationsuccessintheeraofemerginginfectiousdiseases
AT achimhorauf helminthcoinfectionsmodulatediseasedynamicsandvaccinationsuccessintheeraofemerginginfectiousdiseases
AT alexanderyawdebrah helminthcoinfectionsmodulatediseasedynamicsandvaccinationsuccessintheeraofemerginginfectiousdiseases